Lisa M. Giles, Director at Durata Therapeutics, Inc. (DRTX), bought 1,000 shares at $10.95 ($11K) on 2013-12-03, disclosed to the SEC on 2013-12-03.
Open-market purchase of $11k DRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| DRTX | BUY | 2014-01-23 | $4K | — | Filing → |